The main limitations of hematopoietic cord blood (CB) transplantation, viz, low cell dosage and delayed reconstitution, can be overcome by ex vivo expansion. CB expansion under conventional culture causes rapid cell differentiation and depletion of hematopoietic stem and progenitor cells (HSPCs) responsible for engraftment. In this study, we use combinatorial cell culture technology (CombiCult®) to identify medium formulations that promote CD133+ CB HSPC proliferation while maintaining their phenotypic characteristics. We employed second-generation CombiCult screens that use electrospraying technology to encapsulate CB cells in alginate beads. Our results suggest that not only the combination but also the order of addition of individual components has a profound influence on expansion of specific HSPC populations. Top protocols identified by the CombiCult screen were used to culture human CD133+ CB HSPCs on nanofiber scaffolds and validate the expansion of the phenotypically defined CD34+CD38lo/−CD45RA−CD90+CD49f+ population of hematopoietic stem cells and their differentiation into defined progeny.
Get full access to this article
View all access options for this article.
References
1.
HidalgoA and FrenettePS. (2005). Enforced fucosylation of neonatal CD34+ cells generates selectin ligands that enhance the initial interactions with microvessels but not homing to bone marrow. Blood, 105:567–575.
2.
KahnJ, BykT, Jansson-SjostrandL, PetitI, ShivtielS, NaglerA, HardanI, DeutschV, GazitZ, et al. (2004). Overexpression of CXCR4 on human CD34+ progenitors increases their proliferation, migration, and NOD/SCID repopulation. Blood, 103:2942–2949.
3.
OhnoN, KajiumeT, SeraY, SatoT and KobayashiM. (2009). Short-term culture of umbilical cord blood-derived CD34 cells enhances engraftment into NOD/SCID mice through increased CXCR4 expression. Stem Cells Dev, 18:1221–1226.
4.
XiaL, McDanielJM, YagoT, DoedenA and McEverRP. (2004). Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow. Blood, 104:3091–3096.
5.
BallenKK, GluckmanE and BroxmeyerHE. (2013). Umbilical cord blood transplantation: the first 25 years and beyond. Blood, 122:491–498.
MichelG, GalambrunC, SirventA, PochonC, BrunoB, JubertC, LoundouA, Yakoub-AghaI, MilpiedN, et al. (2016). Single versus double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome. Blood, 127:3450–3457.
8.
EngertA, BalduiniC, BrandA, CoiffierB, CordonnierC, DohnerH, de WitTD, EichingerS, FibbeW, et al. (2016). The European hematology association roadmap for European hematology research: a consensus document. Haematologica, 101:115–208.
9.
GenoveseP, SchiroliG, EscobarG, Di TomasoT, FirritoC, CalabriaA, MoiD, MazzieriR, BoniniC, et al. (2014). Targeted genome editing in human repopulating haematopoietic stem cells. Nature, 510:235–240.
10.
PernetO, YadavSS and AnDS. (2016). Stem cell-based therapies for HIV/AIDS. Adv Drug Deliv Rev, 1:187–201.
11.
BaronF, RuggeriA and NaglerA. (2016). Methods of ex vivo expansion of human cord blood cells: challenges, successes and clinical implications. Expert Rev Hematol, 9:297–314.
12.
DarghouthD, GiarratanaM-C, OliveiraL, JollyS, MarieT, BoudahS, MarioN, JunotC, DouayL and RomeoP-H. (2016). Bio-engineered and native red blood cells from cord blood exhibit the same metabolomic profile. Haematologica, 101:e220–e222.
13.
de LimaM, McNieceI, RobinsonSN, MunsellM, EapenM, HorowitzM, AlousiA, SalibaR, McMannisJD, et al. (2012). Cord-blood engraftment with ex vivo mesenchymal-cell coculture. N Engl J Med, 367:2305–2315.
14.
DelaneyC, HeimfeldS, Brashem-SteinC, VoorhiesH, MangerRL and BernsteinID. (2010). Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med, 16:232–236.
HorwitzME. (2016). Ex vivo expansion or manipulation of stem cells to improve outcome of umbilical cord blood transplantation. Curr Hematol Malig Rep, 11:12–18.
17.
WagnerJE, BrunsteinCG, BoitanoAE, DeForTE, McKennaD, SumstadD, BlazarBR, TolarJ, LeC, et al. (2015). Phase I/II trial of StemRegenin-1 expanded umbilical cord blood hematopoietic stem cells supports testing as a stand-alone graft. Cell Stem Cell, 18:1–12.
18.
de WynterEA, BuckD, HartC, HeywoodR, CoutinhoLH, ClaytonA, RaffertyJA, BurtD, GuenecheaG, et al. (1998). CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells, 16:387–396.
19.
McGuckinCP, PearceD, ForrazN, ToozeJA, WattSM and PettengellR. (2003). Multiparametric analysis of immature cell populations in umbilical cord blood and bone marrow. Eur J Haematol, 71:341–350.
20.
RadtkeS, GörgensA, KordelasL, SchmidtM, KimmigKR, KöningerA, HornPA and GiebelB. (2015). CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants. Br J Haematol, 169:868–878.
21.
TakahashiM, MatsuokaY, SumideK, NakatsukaR, FujiokaT, KohnoH, SasakiY, MatsuiK, AsanoH, KanekoK and SonodaY. (2014). CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells. Leukemia, 28:1308–1315.
22.
YinAH, MiragliaS, ZanjaniED, Almeida-PoradaG, OgawaM, LearyAG, OlweusJ, KearneyJ and BuckDW. (1997). AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood, 90:5002–5012.
23.
NottaF, DoulatovS, LaurentiE, PoepplA, JurisicaI and DickJE. (2011). Isolation of single human hematopoietic stem cells capable of long-term multilineage engraftment. Science, 333:218–221.
ChooY. (2008). Use of combinatorial screening to discover protocols that effectively direct the differentiation of stem cells. In: Stem Cell Research and Therapeutics. ShiDOCY, ed. Springer Science + Business Media, Dordrecht, Netherlands. pp 227–250.
26.
TaruninaM, HernandezD, JohnsonCJ, RybtsovS, RamathasV, JeyakumarM, WatsonT, HookL, MedvinskyA, MasonC and ChooY. (2014). Directed differentiation of embryonic stem cells using a bead-based combinatorial screening method. PLoS One, 9:e104301.
27.
ChooY, JohnsonCJ, OdenwalderPK and Jayasinghe.SN (2011). Nested cell encapsulation. Patent WO 2011/047870.
28.
ArumuganatharS, SuterN, WalzelP and JayasingheSN. (2009). Aerodynamically assisted jetting and threading for processing concentrated suspensions containing advanced structural, functional and biological materials. Biotechnol J, 4:64–72.
29.
MatsumotoM and NishimuraT. (1998). Mersenne twister: a 623-dimensionally equidistributed uniform pseudo-random number generator. ACM Trans Model Comput Simul, 8:3–30.
30.
GulloF, Van Der GardeM, RussoG, PennisiM, MottaS, PappalardoF and WattS. (2015). Computational modeling of the expansion of human cord blood CD133+ hematopoietic stem/progenitor cells with different cytokine combinations. Bioinformatics, 31:2514–2522.
31.
PepperellEE and WattSM. (2013). A novel application for a 3-dimensional timelapse assay that distinguishes chemotactic from chemokinetic responses of hematopoietic CD133(+) stem/progenitor cells. Stem Cell Res, 11:707–720.
32.
ChangC-H, HaleSJ, CoxCV, BlairA, KronsteinerB, GrabowskaR, ZhangY, CookD, KhooCP, et al. (2016). Junctional adhesion molecule-A is highly expressed on human hematopoietic repopulating cells and associates with the key hematopoietic chemokine receptor cxcr4. Stem Cells, 34:1664–1678.
33.
SchluterC, DuchrowM, WohlenbergC, BeckerMHG, KeyG, FladHD and GerdesJ. (1993). The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol, 123:513–522.
34.
De FeliceL, Di PucchioT, BrecciaM, AgostiniF, MascoloMG, GuglielmiC, RicciardiMR, ScrenciM, TafuriA, CarminiD and ArceseW. (1998). Flt3L enhances the early stem cell compartment after ex vivo amplification of umbilical cord blood CD34+ cells. Bone Marrow Transplant, 22 (Suppl. 1):S66–S67.
35.
HaylockDN, HorsfallMJ, DowseTL, RamshawHS, NiuttaS, ProtopsaltisS, PengL, BurrellC, RappoldI, BuhringHJ and SimmonsPJ. (1997). Increased recruitment of hematopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand. Blood, 90:2260–2272.
36.
YeohJSG, van OsR, WeersingE, AusemaA, DontjeB, VellengaE and de HaanG. (2006). Fibroblast growth factor-1 and -2 preserve long-term repopulating ability of hematopoietic stem cells in serum-free cultures. Stem Cells, 24:1564–1572.
37.
ZhangCC, KabaM, IizukaS, HuynhH and LodishHF. (2008). Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. Blood, 111:3415–3423.
DahlbergA, WooS, DelaneyC, BoyleP, GnirkeA, BockC, BernsteinBE, MeissnerA, GottardoR and BernsteinID. (2015). Notch-mediated expansion of cord blood progenitors: maintenance of transcriptional and epigenetic fidelity. Leukemia, 29:1948–1951.
40.
JiangJ, ZhaoM, ZhangA, YuM, LinX, WuM, WangX, LuH, ZhuS, et al. (2010). Characterization of a GSK-3 inhibitor in culture of human cord blood primitive hematopoietic cells. Biomed Pharmacother, 64:482–486.
41.
ParkH-S and JunC-H. (2009). A simple and fast algorithm for K-medoids clustering. Expert Syst Appl, 36:3336–3341.
42.
van der GardeM, van HensbergenY, BrandA, SlotMC, de Graaf-DijkstraA, MulderA, WattSM and ZwagingaJJ. (2015). Thrombopoietin treatment of one graft in a double cord blood transplant provides early platelet recovery while contributing to long-term engraftment in NSG mice. Stem Cells Dev, 24:67–76.
43.
CheungAMS, NguyenLV, CarlesA, BeerP, MillerPH, KnappDJHF, DhillonK, HirstM and EavesCJ (2013). Analysis of the clonal growth and differentiation dynamics of primitive barcoded human cord blood cells in NSG mice. Blood, 122:3129–3137.
LiL, KimHT, NelloreA, PatsoukisN, PetkovaV, McDonoughS, PolitikosI, NikiforowS, SoifferR, et al. (2014). Prostaglandin E2 promotes survival of naive UCB T cells via the Wnt/beta-catenin pathway and alters immune reconstitution after UCBT. Blood Cancer J, 4:e178.
LombardoA and NaldiniL. (2014). Genome editing: a tool for research and therapy: targeted genome editing hits the clinic. Nat Med, 20:1101–1103.
48.
DahlbergA, Brashem-SteinC, DelaneyC and BernsteinID. (2014). Enhanced generation of cord blood hematopoietic stem and progenitor cells by culture with StemRegenin1 and Delta1(Ext-IgG.). Leukemia, 28:2097–2101.
49.
DrakeAC, KhouryM, LeskovI, IliopoulouBP, FragosoM, LodishH and ChenJ. (2011). Human CD34+ CD133+ hematopoietic stem cells cultured with growth factors including Angptl5 efficiently engraft adult NOD-SCID Il2rγ-/- (NSG) mice. PLoS One, 6:e18382.
50.
LechmanER, GentnerB, NgSWK, SchoofEM, van GalenP, KennedyJA, NuceraS, CiceriF, KaufmannKB, et al. (2016). miR-126 regulates distinct self-renewal outcomes in normal and malignant hematopoietic stem cells. Cancer Cell, 29:214–228.
51.
PeledT, MandelJ, GoudsmidRN, LandorC, HassonN, HaratiD, AustinM, HassonA, FibachE, ShpallEJ and Naglera. (2004). Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine. Cytotherapy, 6:344–355.
52.
PiacibelloW, GammaitoniL, BrunoS, GunettiM, FagioliF, CavalloniG and AgliettaM. (2000). Negative influence of IL3 on the expansion of human cord blood in vivo long-term repopulating stem cells. J Hematother Stem Cell Res, 9:945–956.
53.
RappoldI, WattSM, KusadasiN, Rose-JohnS, HatzfeldJ and PloemacherRE. (1999). Gp130-signaling synergizes with FL and TPO for the long-term expansion of cord blood progenitors. Leukemia, 13:2036–2048.
54.
FaresI, ChagraouiJ, GareauY, GingrasS, RuelR, MayotteN, CsaszarE, KnappDJHF, MillerP, et al. (2014). Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal. Science, 345:1509–1512.
55.
BoitanoAE, WangJ, RomeoR, BouchezLC, ParkerAE, SuttonSE, WalkerJR, FlavenyCA, PerdewGH, et al. (2010). Aryl hydrocarbon receptor antagonist promote the expansion of human hematopoetic stem cells. Science, 329:1345–1348.
56.
FamiliF, BrugmanMH, TaskesenE, NaberBEA, FoddeR and StaalFJT. (2016). High levels of canonical Wnt signaling lead to loss of stemness and increased differentiation in hematopoietic stem cells. Stem Cell Reports, 6:652–659.
57.
YuVWC and ScaddenDT. (2016). Heterogeneity of the bone marrow niche. Curr Opin Hematol, 23:331–338.
58.
MathewsLA, KellerJM, McKnightC, MichaelS, ShinnP, LiuD, StaudtLM, ThomasCJ and FerrerM. (2013). Multiplexing high-content flow (HCF) and quantitative high-throughput screening (qHTS) to identify compounds capable of decreasing cell viability, activating caspase 3/7, expressing annexin V, and changing mitochondrial membrane integrity. Curr Protoc Chem Biol, 5:195–212.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
